Clinical Trials Logo

Clinical Trial Summary

Objective: Referring The relation between CEA(Carotid endarterectomy) postoperative blood flow monitoring and blood pressure, and combining patient demographics and preoperative risk factors to establish an applicable individual blood pressure controlling model. By comparing with routine antihypertensive strategies through prospective randomized controlled trials , to provide the best perioperative blood pressure control standards and strategies for each patient ,thus better ensuring the safety and efficacy of CEA .


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03256513
Study type Interventional
Source Xuanwu Hospital, Beijing
Contact Liqun Jiao, MD
Phone 86-10-83198899
Email jiaoliqun@gmail.com
Status Recruiting
Phase N/A
Start date April 10, 2017
Completion date June 1, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT03589053 - Limb Remote Ischemic Conditioning and Cerebrovascular Reserve Phase 2
Enrolling by invitation NCT01925872 - Optimal Regimen in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance N/A
Not yet recruiting NCT03153878 - The Prospective Cohort Study on the Benefit-risk of Antithrombotic or Anticoagulant Therapy in Patients With Unruptured Intracranial Aneurysms Associated With Ischemic Heart Disease or Ischemic Cerebrovascular Disease N/A
Completed NCT02966418 - Hypoxic Preconditioning on Patients N/A
Recruiting NCT05232240 - Blood Pressure Variability in Non-hypertensive Patients With Ischemic Cerebrovascular Disease
Not yet recruiting NCT06001073 - Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
Recruiting NCT03794843 - Bioavailability Comparison Study of Two Types of Nimodipine Injections in Healthy Volunteers Early Phase 1
Not yet recruiting NCT05716646 - In the Real World Study, the Efficacy and Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular Disease